Your Search Results

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options

21 Nov 2021 – From PCR London Valves 2021

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...

Coronaries and TAVI

21 Nov 2021 – From PCR London Valves 2021

Watch this series of videos and learn about TAVR in rheumatic patient with aortic regurgitation, IVUS assessment of coronary ostia following transapical ViV TAVI, "Hybrid thinking" off-pump CABG and TAVI for left main disease and CTO with severe aortic stenosis, and more!

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure

21 Nov 2021 – From PCR London Valves

In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...

From TAVI to mitral and tricuspid - Part 1 - Best long-term outcomes start with the first procedure

Unusual situations during TAVI

21 Nov 2021 – From PCR London Valves 2021

Watch this PCR London Valves 2021 session to benefit from the experience of our speakers and discover, among others, ECMO assistance during TAVI in high-risk patient with recent COVID-19 pneumonia, bailout "balloon trapping technic" to facilitate crossing the aortic valve during TAVI, or how to manage residual...

From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options

22 Nov 2021 – From PCR London Valves

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key...

From TAVI to mitral and tricupid - Part 2 - Securing long-term patient options

Innovation and imaging guidance for tricuspid valve replacement

21 Nov 2021 – From PCR London Valves

Watch this TNT session broadcast at PCR London Valves 2021 Congress to learn more about the crucial importance of understanding imaging and having high-quality imaging to guide transcatheter tricuspid valve intervention.

Innovation and imaging guidance for tricuspid valve replacement

Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis

21 Nov 2021 – From PCR London Valves 2021

Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.

EAPCI: patient initiatives around the world

22 Nov 2021 – From PCR London Valves 2021

In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.

EAPCI: patient initiatives around the world

Cases on miscellaneous coronary interventions

15 Dec 2021 – From GulfPCR-GIM 2021

Watch this session to discover a selection of cases on miscellaneous coronary interventions unveiled at GulfPCR-GIM 2021: imaging-guided multivessel PCI in left main with TVD with rotablation in a ESRD, tiger catheter-induced left main occlusion, using IVL instead of rotational atherectomy, PCI of LIMA-LAD at anastomotic site in single surviving artery, aortocoronary dissection...

Cases on STEMI

15 Dec 2021 – From GulfPCR-GIM 2021

Watch this session to discover a selection of STEMI cases presented at GulfPCR-GIM 2021, and learn more about: the treatment of intramural haematoma and AMI, the role of plaque modifying device in ACS, the therapeutic strategy for a pan-coronary vulnerability, the importance of stent visualisation to improve...

TAVI procedure optimisation with the cusp overlap technique

27 Sep 2021 – From PCR Tokyo Valves 2021

In this session, the speakers present the advantages of the cusp overlap technique, providing a technical overview, and predicting that it will lead to best-in-class permanent pacemaker implantation rates, and will also have a great impact on paravalvular leak rates and other clinical endpoints. They further support their point by...

TAVI procedure optimisation with the cusp overlap technique

Addressing the challenges of small annuli patients with the Evolut Platform

27 Sep 2021 – From PCR Tokyo Valves 2021

Recognizing that Asian patients, especially women with aortic stenosis, are smaller and have smaller annuli than European ones, for instance, this session discusses the challenges of treating these patients, among them prosthesis patient mismatch, annulus rupture, coronary occlusion, or vascular complication. In addition, the speakers will draw...

Addressing the challenges of small annuli patients with the Evolut Platform

Introducing Navitor: a new TAVR solution with an active paravalvular leak-sealing technology

27 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session to view the live case from Copenhagen of a 77-year-old woman with severe aortic valve stenosis NYHA III, to get a precise description of the features of the Navitor system and the Naviseal technology, a new solution for reducing risk of paravalvular leak,...